Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls

Silvia Canivell; Sandra Rebuffat; Elena G. Ruano; Belchin Kostov; Antoni Sisó-Almirall; Anna Novials; Antonio Ceriello; Ramon Gomis

doi:10.1002/dmrr.2599

Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls

Silvia Canivell, Sandra Rebuffat, Elena G. Ruano, Belchin Kostov, Antoni Sisó-Almirall, Anna Novials, Antonio Ceriello, Ramon Gomis

IRCCS Multimedica

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Secreted frizzled-related protein 5 (SFRP5) has been linked to obesity. Results are conflicting regarding its association with type 2 diabetes (T2D) in humans. We aimed to investigate circulating SFRP5 in prediabetes and T2D and its potential association with parameters of insulin resistance and beta-cell function. Methods: We studied 70 drug-naïve T2D patients, 70 prediabetic subjects and 70 controls. All subjects were body mass index matched to the T2D patients and overweight or obese. SFRP5, hormones and cytokines levels were measured by ELISA. Results: Serum SFRP5 levels were elevated in T2D patients as compared with prediabetic subjects (median 15.6, interquartile range [9-24.5]ng/mL vs 9.8 [5-14.2]ng/mL, p

Original language	English
Pages (from-to)	212-219
Number of pages	8
Journal	Diabetes/Metabolism Research and Reviews
Volume	31
Issue number	2
DOIs	https://doi.org/10.1002/dmrr.2599
Publication status	Published - Feb 1 2015

Keywords

Adipokines
Diabetes mellitus, type 2
Obesity
Prediabetic state
Secreted frizzled-related protein 5, human

ASJC Scopus subject areas

Endocrinology
Endocrinology, Diabetes and Metabolism
Internal Medicine
Medicine(all)

Access to Document

10.1002/dmrr.2599

Fingerprint Dive into the research topics of 'Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls'. Together they form a unique fingerprint.

Cite this

Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. / Canivell, Silvia; Rebuffat, Sandra; G. Ruano, Elena; Kostov, Belchin; Sisó-Almirall, Antoni; Novials, Anna; Ceriello, Antonio; Gomis, Ramon.

In: Diabetes/Metabolism Research and Reviews, Vol. 31, No. 2, 01.02.2015, p. 212-219.

Research output: Contribution to journal › Article › peer-review

Canivell, Silvia ; Rebuffat, Sandra ; G. Ruano, Elena ; Kostov, Belchin ; Sisó-Almirall, Antoni ; Novials, Anna ; Ceriello, Antonio ; Gomis, Ramon. / Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. In: Diabetes/Metabolism Research and Reviews. 2015 ; Vol. 31, No. 2. pp. 212-219.

@article{4987d68ee73945ed9dd411399fe8fcb2,

title = "Circulating SFRP5 levels are elevated in drug-na{\"i}ve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls",

abstract = "Background: Secreted frizzled-related protein 5 (SFRP5) has been linked to obesity. Results are conflicting regarding its association with type 2 diabetes (T2D) in humans. We aimed to investigate circulating SFRP5 in prediabetes and T2D and its potential association with parameters of insulin resistance and beta-cell function. Methods: We studied 70 drug-na{\"i}ve T2D patients, 70 prediabetic subjects and 70 controls. All subjects were body mass index matched to the T2D patients and overweight or obese. SFRP5, hormones and cytokines levels were measured by ELISA. Results: Serum SFRP5 levels were elevated in T2D patients as compared with prediabetic subjects (median 15.6, interquartile range [9-24.5]ng/mL vs 9.8 [5-14.2]ng/mL, p",

keywords = "Adipokines, Diabetes mellitus, type 2, Obesity, Prediabetic state, Secreted frizzled-related protein 5, human",

author = "Silvia Canivell and Sandra Rebuffat and {G. Ruano}, Elena and Belchin Kostov and Antoni Sis{\'o}-Almirall and Anna Novials and Antonio Ceriello and Ramon Gomis",

year = "2015",

month = feb,

day = "1",

doi = "10.1002/dmrr.2599",

language = "English",

volume = "31",

pages = "212--219",

journal = "Diabetes/Metabolism Research and Reviews",

issn = "1520-7552",

publisher = "John Wiley and Sons Ltd",

number = "2",

}

TY - JOUR

T1 - Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls

AU - Canivell, Silvia

AU - Rebuffat, Sandra

AU - G. Ruano, Elena

AU - Kostov, Belchin

AU - Sisó-Almirall, Antoni

AU - Novials, Anna

AU - Ceriello, Antonio

AU - Gomis, Ramon

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Background: Secreted frizzled-related protein 5 (SFRP5) has been linked to obesity. Results are conflicting regarding its association with type 2 diabetes (T2D) in humans. We aimed to investigate circulating SFRP5 in prediabetes and T2D and its potential association with parameters of insulin resistance and beta-cell function. Methods: We studied 70 drug-naïve T2D patients, 70 prediabetic subjects and 70 controls. All subjects were body mass index matched to the T2D patients and overweight or obese. SFRP5, hormones and cytokines levels were measured by ELISA. Results: Serum SFRP5 levels were elevated in T2D patients as compared with prediabetic subjects (median 15.6, interquartile range [9-24.5]ng/mL vs 9.8 [5-14.2]ng/mL, p

AB - Background: Secreted frizzled-related protein 5 (SFRP5) has been linked to obesity. Results are conflicting regarding its association with type 2 diabetes (T2D) in humans. We aimed to investigate circulating SFRP5 in prediabetes and T2D and its potential association with parameters of insulin resistance and beta-cell function. Methods: We studied 70 drug-naïve T2D patients, 70 prediabetic subjects and 70 controls. All subjects were body mass index matched to the T2D patients and overweight or obese. SFRP5, hormones and cytokines levels were measured by ELISA. Results: Serum SFRP5 levels were elevated in T2D patients as compared with prediabetic subjects (median 15.6, interquartile range [9-24.5]ng/mL vs 9.8 [5-14.2]ng/mL, p

KW - Adipokines

KW - Diabetes mellitus, type 2

KW - Obesity

KW - Prediabetic state

KW - Secreted frizzled-related protein 5, human

UR - http://www.scopus.com/inward/record.url?scp=84922667479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922667479&partnerID=8YFLogxK

U2 - 10.1002/dmrr.2599

DO - 10.1002/dmrr.2599

M3 - Article

C2 - 25139699

AN - SCOPUS:84922667479

VL - 31

SP - 212

EP - 219

JO - Diabetes/Metabolism Research and Reviews

JF - Diabetes/Metabolism Research and Reviews

SN - 1520-7552

IS - 2

ER -